|
Volumn 44, Issue 6, 2012, Pages 1571-1573
|
Early and extended therapy for recurrent hepatitis C after liver transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ERYTHROPOIETIN;
GRANULOCYTE COLONY STIMULATING FACTOR;
PEGINTERFERON ALPHA2A PLUS RIBAVIRIN;
ADULT;
AGED;
ANEMIA;
ANTIVIRAL THERAPY;
CLINICAL ARTICLE;
CONFERENCE PAPER;
DISEASE SEVERITY;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
DRUG HYPERSENSITIVITY;
DRUG INDICATION;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
EARLY INTERVENTION;
FEMALE;
HEPATITIS C;
HISTOPATHOLOGY;
HUMAN;
LEUKOPENIA;
LIVER CIRRHOSIS;
LIVER FIBROSIS;
LIVER TRANSPLANTATION;
MALE;
MENTAL DISEASE;
PRIORITY JOURNAL;
RECURRENT INFECTION;
TREATMENT DURATION;
TREATMENT RESPONSE;
ADULT;
AGED;
ANTIVIRAL AGENTS;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HEPATITIS C;
HUMANS;
INTERFERON-ALPHA;
LIVER CIRRHOSIS;
LIVER TRANSPLANTATION;
LOGISTIC MODELS;
MALE;
MIDDLE AGED;
MULTIVARIATE ANALYSIS;
POLYETHYLENE GLYCOLS;
RECOMBINANT PROTEINS;
RECURRENCE;
RIBAVIRIN;
RISK ASSESSMENT;
RISK FACTORS;
SEVERITY OF ILLNESS INDEX;
SPAIN;
TIME FACTORS;
TREATMENT OUTCOME;
VIRUS ACTIVATION;
|
EID: 84864404486
PISSN: 00411345
EISSN: 18732623
Source Type: Journal
DOI: 10.1016/j.transproceed.2012.05.027 Document Type: Conference Paper |
Times cited : (2)
|
References (6)
|